Using A.I. For Health Care: Oklahoma Biotech Company Partnering With OKC Innovation District

An Oklahoma-based biotech company is teaming up with the Oklahoma City Innovation District to use artificial Intelligence to help predict health changes in patients.

General Genomics believes their technology will save lives.

The product is very advanced, but the passion behind it is what really sets them apart.

"My son asked me whether or not he would die from Covid and if he would be able to see his friends again."

That question caused A.J. Rosenthal, co-founder of General Genomics, to work toward change.

"How can we help; how can we make it easier for doctors," Rosenthal said.

A technology that can help you understand your risk for developing diseases.

"What we are trying to do is empower the patient and teach the patient why seeing new things about their health... Understanding genomically what predispositions we have, so say your mother might have had something in her past and that overtime comes into your life and you don't know why," Rosenthal said.

For Dr. Robert Frantz, his service to Oklahomans runs deep.

"I was a paramedic and a police officer here in Norman, Oklahoma, for seven years, and then I went to medical school at the university."

And he knows Oklahoma is the place to make innovations happen,

"This is everything, we are becoming known, you know, we have the health science center and all of these wonderful leaders, buildings and technology here. This is exactly where it should be coming from right in the center of the heart of the country," Frantz said.

Right now, the company said it is still in the early stages of creating this technology and working to get it into the hands of physicians.